PMDA — authorised 29 June 2020
- Marketing authorisation holder: Novartis Pharma K.K.
- Status: approved
🇯🇵 Arcapta Neohaler in Japan
PMDA authorised Arcapta Neohaler on 29 June 2020
Marketing authorisation
Arcapta Neohaler in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Japan
Frequently asked questions
Is Arcapta Neohaler approved in Japan?
Yes. PMDA authorised it on 29 June 2020.
Who is the marketing authorisation holder for Arcapta Neohaler in Japan?
Novartis Pharma K.K. holds the Japanese marketing authorisation.